[Form 4] Aptiv PLC Insider Trading Activity

Rhea-AI Filing Summary

Joseph R. Massaro, Vice Chairman, ECG of Aptiv PLC (APTV), reported an insider sale. The filing shows a sale of 35,000 ordinary shares on 08/21/2025 at a price of $74.36 per share, after which the reporting person beneficially owned 329,392 shares. The Form 4 states the transactions were effected under a Rule 10b5-1 trading plan adopted May 22, 2025, indicating the sale was preplanned rather than ad hoc. The form was signed by an attorney-in-fact on behalf of Massaro on 08/25/2025. The filing contains no additional disclosures about the purpose of the sale or other transactions.

Positive

• Transaction executed under a Rule 10b5-1 trading plan, which provides an affirmative defense against insider trading claims
• Timely and complete disclosure of the sale, price, transaction date, and resulting beneficial ownership

Negative

• Senior officer disposed of 35,000 shares, which reduces the reporting person's stake to 329,392 shares
• No explanation provided in the filing for the purpose of the sale or use of proceeds

Insights

Corporate Governance Expert

TL;DR: Insider sale executed under a 10b5-1 plan, timely disclosed; limited material implications absent further context.

The Form 4 reports a deliberate disposition of 35,000 ordinary shares by a senior officer under a Rule 10b5-1 plan adopted May 22, 2025. Use of an established trading plan provides procedural protection against insider trading allegations and suggests the sale was scheduled rather than opportunistic. The filing is concise and includes the number of shares remaining beneficially owned, which helps assess ongoing insider exposure. There is no accompanying explanation of proceeds use or other contemporaneous transactions, and no evidence in this filing of unusual timing or related-party issues. On its face, the disclosure is routine for an officer sale.

Securities Analyst

TL;DR: Transaction is a routine, pre-planned insider sale with straightforward disclosure; not clearly material by itself.

The recorded sale of 35,000 shares at $74.36 per share is clearly documented and executed under a 10b5-1 plan, reducing the reporting person's beneficial holdings to 329,392 shares. For investors, the key takeaway is transparency of execution and the presence of a trading plan, which reduces information asymmetry concerns. The filing lacks any additional transactions, option exercises, or derivative positions, so its standalone market impact is likely limited. Further context—such as the officer's historical trading, total insider holdings companywide, or concurrent corporate events—would be required to assess broader significance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Massaro Joseph R

(Last) (First) (Middle)

5725 INNOVATION DRIVE

(Street)

TROY MI 48098

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aptiv PLC [ APTV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice Chairman, ECG

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/21/2025		S(1)		35,000	D	$74.36	329,392	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2025.

	/s/ Rachel V. Friedenberg, Attorney-in-fact for Joseph R. Massaro	08/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Aptiv insider Joseph R. Massaro disclose on Form 4 (APTV)?

The Form 4 discloses a sale of 35,000 ordinary shares on 08/21/2025 at $74.36 per share; post-transaction beneficial ownership was 329,392 shares.

Was the 35,000-share sale by the Aptiv insider part of a 10b5-1 plan?

Yes. The Form 4 states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted May 22, 2025.

Who filed the Form 4 on behalf of Joseph R. Massaro?

The Form 4 was signed by Rachel V. Friedenberg, Attorney-in-fact for Joseph R. Massaro on 08/25/2025.

What price per share was reported for the insider sale of Aptiv stock?

The reported sale price was $74.36 per share for the 35,000 shares sold on 08/21/2025.

Does the Form 4 show any derivative transactions or option exercises for Massaro?

No. Table II for derivative securities contains no reported transactions; only the non-derivative sale is disclosed.